(Q42553765)

2 November 2017

title

Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine (English)

1 reference

2 November 2017

H Rupp

1

1 reference

2 November 2017

B Maisch

series ordinal

2

1 reference

2 November 2017

C G Brilla

series ordinal

3

1 reference

2 November 2017

publication date

1 June 1996

1 reference

Cardiovascular Drugs and Therapy

2 November 2017

published in

1 reference

2 November 2017

volume

10 Suppl 1

1 reference

2 November 2017

page(s)

251-262

1 reference

The central action of antihypertensive drugs, mediated via central alpha-receptors

2 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00120495

Clonidine withdrawal. Mechanism and frequency of rebound hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00120495

Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00120495

Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease

21 January 2018

1 reference

12 December 2020

Pharmacological approaches to appetite suppression

1 reference

12 December 2020

Vascular responsiveness of rabbit common carotid, renal and femoral arteries to alpha-adrenoceptor agonists

1 reference

12 December 2020

The over-shoot phenomenon on withdrawal of clonidine therapy

1 reference

12 December 2020

A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

1 reference

12 December 2020

Environmental factors in the development of essential hypertension

1 reference

12 December 2020

Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats

1 reference

12 December 2020

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline

1 reference

12 December 2020

Excess catecholamines and the metabolic syndrome: Should central imidazoline receptors be a therapeutic target?

1 reference

12 December 2020

Clinical experience with moxonidine

1 reference

12 December 2020

Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension

1 reference

12 December 2020

Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow

1 reference

12 December 2020

I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.

1 reference

12 December 2020

Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors

1 reference

12 December 2020

1 reference

12 December 2020

Twenty-four-hour blood pressure profiles in patients with mild-to-moderate hypertension: moxonidine versus captopril.

1 reference

12 December 2020

Receptor mechanisms for clonidine reversal of bupivacaine-induced impairment of ventricular conduction in pentobarbital-anesthetized dogs.

1 reference

12 December 2020

Pharmacology of centrally acting hypotensive drugs

1 reference

12 December 2020

Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents

1 reference

12 December 2020

Central α-adrenergic systems as targets for hypotensive drugs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00120495

1 reference

release_ab5iqw4sdza25fadxcrqv2axim

2 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ab5iqw4sdza25fadxcrqv2axim

24 November 2022

mapped directly with Wikidata item

1 reference